글로벌 전체 슬라이드 이미징 시장 – 2031년까지의 산업 동향 및 예측

전체 슬라이드 이미징 시장 분석 및 규모

병리학 및 진단 분야에서 전체 슬라이드 이미징은 질병, 특히 암을 진단하는 방법을 혁신하고 있습니다. WSI를 사용하면 병리학자가 전체 유리 슬라이드를 디지털화하여 컴퓨터 화면에서 분석할 수 있는 고해상도 이미지를 만들 수 있습니다. 이러한 디지털 방식은 고급 이미지 분석 기술과 인공 지능 을 사용하여 진단 정확도와 효율성을 향상시킵니다 . 또한 WSI는 원격 진단을 용이하게 하여 병리학자가 전 세계 어디에서나 슬라이드에 액세스하고 평가할 수 있으므로 전문가 의견에 대한 접근성을 개선하고 진단 지연을 줄일 수 있습니다.

글로벌 슬라이드 이미징 시장 규모는 2023년에 10억 4천만 달러로 평가되었으며, 2031년까지 33억 9천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 15.90%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화       

Market Definition

Whole slide imaging (WSI) is a process that involves scanning traditional glass microscope slides to create high-resolution digital images of the entire tissue sample. These digital slides can be viewed, analyzed, and shared on computer screens, enabling remote diagnosis, digital archiving, and advanced image analysis. Whole slide imaging is widely used in pathology for educational, clinical, and research purposes.

Whole Slide Imaging Market Dynamics

Drivers

• Growing Supportive Government Policies

Government worldwide are increasingly recognizing the benefits of digital pathology and are implementing policies to promote its adoption. Initiatives include funding for healthcare technology upgrades, grants for research and development in digital pathology, and regulatory frameworks that encourage the use of digital tools in medical diagnostics. These policies aim to improve diagnostic accuracy, reduce healthcare costs, and enhance patient care. By providing financial incentives and regulatory support, governments are facilitating the widespread implementation of whole slide imaging technologies in medical institutions.

• Rising Prevalence of Chronic Diseases

Rising chronic diseases demands for accurate and efficient diagnostic tools that can handle large volumes of tissue samples with high precision. WSI addresses these needs by digitizing entire pathology slides, allowing pathologists to analyze samples more comprehensively and accurately. This technology facilitates earlier detection, precise diagnosis, and personalized treatment planning, crucial in managing chronic diseases effectively. Moreover, WSI supports research efforts aimed at understanding disease mechanisms and developing new therapies, further driving its adoption in healthcare systems worldwide.

Opportunities

• Advancements in Digital Pathology

Advancements in digital pathology include significant improvements in imaging technologies, such as higher resolution scanners and faster image processing capabilities, which enhance the quality and efficiency of slide digitization. Integration of artificial intelligence (AI) and machine learning algorithms further improves diagnostic accuracy by assisting pathologists in analyzing digital slides. Moreover, digital pathology enables seamless integration with electronic health records (EHRs) and laboratory information systems (LIS), streamlining workflow and enhancing data management. These technological advancements boost diagnostic capabilities and support remote consultations, telepathology, and collaborative research efforts, thereby driving the adoption of whole slide imaging across healthcare settings worldwide.

• Growth in Research and Development

Whole slide imaging enables researchers to efficiently analyze large volumes of tissue samples with high-resolution digital images, facilitating more detailed and accurate investigations into diseases and treatments. This capability is crucial in pharmaceutical and biotechnology sectors for drug discovery, efficacy testing, and toxicology studies. Additionally, whole slide imaging supports collaborative research efforts by allowing seamless sharing and remote access to digital slides among researchers globally, enhancing productivity and accelerating scientific discoveries.

Restraints/Challenges

• High Initial Investment

Whole slide imaging systems involve substantial costs for acquiring scanners, digital slide management software, and IT infrastructure capable of handling large image data. These upfront expenses can be prohibitive for smaller healthcare facilities, pathology labs, and research institutions, limiting their ability to adopt WSI technology. Moreover, ongoing maintenance and upgrade costs add to the financial burden.

• Growing Management Challenges

Management challenges include establishing robust storage solutions capable of managing massive image files securely and efficiently. Additionally, integrating WSI systems with existing laboratory information systems (LIS) and electronic health records (EHR) can be technically demanding and costly. Training pathologists and laboratory personnel to effectively use WSI technology and ensuring compliance with data privacy regulations further complicate implementation.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Whole Slide Imaging Market Scope

The market is segmented on the basis of technology, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

• Scanners
• IT Infrastructure
• Viewer
• Image Management System

Application

• Telepathology
• Cytopathology
• Immunohistochemistry
• Hematopathology

End User

• Hospitals
• Pharmaceutical and Biopharmaceutical Companies
• Laboratories
• Academic Institute
• Research
• Others

Whole Slide Imaging Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, technology, application and end user as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America.

Asia-Pacific dominates the market due to significant advancements in drug discovery research and growing awareness of the technology's benefits. Increased investment in healthcare infrastructure and the rising prevalence of chronic diseases also drive market growth. Additionally, government initiatives supporting digital pathology further bolster the adoption of whole slide imaging in the region.

North America is expected to experience substantial growth in the market due to increased government initiatives promoting the adoption of advanced technologies. This growth is further fueled by a rise in research and development activities across various industries. The region's emphasis on innovation and technological advancements is expected to drive significant market expansion during this period.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

의료 인프라 성장 설치 기반 및 신기술 침투

이 시장은 또한 자본 장비에 대한 의료 지출의 모든 국가별 성장, 시장에 대한 다양한 종류의 제품의 설치 기반, 수명선 곡선을 사용한 기술의 영향, 의료 규제 시나리오의 변화 및 시장에 미치는 영향에 대한 자세한 시장 분석을 제공합니다. 이 데이터는 2016-2021년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 전체 슬라이드 이미징 시장 분석

시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 활동하는 주요 기업은 다음과 같습니다.

• 올림푸스 주식회사(일본)
• Leica Biosystems Nussloch GmbH(독일)
• 하마마츠 포토닉스 주식회사(일본)
• 3DHISTECH Ltd. (헝가리)
• Koninklijke Philips NV(네덜란드)
• 인디카 랩스(Indica Labs, Inc.) (미국)
• 인스피라타 주식회사(미국)
• Nikon Instruments Inc. (일본)
• Mikroscan Technologies, Inc. (미국)
• Visiopharm A/S(덴마크)
• 퍼킨엘머 주식회사(미국)
• 아코야 바이오사이언스 주식회사(미국)
• 지멘스 헬스키니어스 AG(독일)
• 홀로직 주식회사(미국)
• Carl Zeiss AG(독일)

SKU-63612